{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:32:08Z","timestamp":1785832328669,"version":"3.56.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T00:00:00Z","timestamp":1372291200000},"content-version":"vor","delay-in-days":177,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2013,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Erythropoietin (EPO) has protective effects in neurodegenerative and neuroinflammatory diseases, including in animal models of multiple sclerosis, where EPO decreases disease severity. EPO also promotes neurogenesis and is protective in models of toxic demyelination. In this study, we asked whether EPO could promote neurorepair by also inducing remyelination. In addition, we investigated whether the effect of EPO could be mediated by the classical erythropoietic EPO receptor (EPOR), since it is still questioned if EPOR is functional in nonhematopoietic cells. Using CG4 cells, a line of rat oligodendrocyte precursor cells, we found that EPO increases the expression of myelin genes (myelin oligodendrocyte glycoprotein (<jats:italic>MOG<\/jats:italic>) and myelin basic protein (<jats:italic>MBP<\/jats:italic>)). EPO had no effect in wild-type CG4 cells, which do not express EPOR, whereas it increased <jats:italic>MOG<\/jats:italic> and <jats:italic>MBP<\/jats:italic> expression in cells engineered to overexpress EPOR (CG4-EPOR). This was reflected in a marked increase in MOG protein levels, as detected by Western blot. In these cells, EPO induced by 10-fold the early growth response gene 2 (<jats:italic>Egr2<\/jats:italic>), which is required for peripheral myelination. However, <jats:italic>Egr2<\/jats:italic> silencing with a siRNA did not reverse the effect of EPO, indicating that EPO acts through other pathways. In conclusion, EPO induces the expression of myelin genes in oligodendrocytes and this effect requires the presence of EPOR. This study demonstrates that EPOR can mediate neuroreparative effects.<\/jats:p>","DOI":"10.2119\/molmed.2013.00013","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T01:07:09Z","timestamp":1376528829000},"page":"223-229","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Erythropoietin (EPO) Increases Myelin Gene Expression in CG4 Oligodendrocyte Cells through the Classical EPO Receptor"],"prefix":"10.1186","volume":"19","author":[{"given":"Ilaria","family":"Cervellini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Annenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Brenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuti","family":"Chernajovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Ghezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Mengozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,27]]},"reference":[{"key":"1901223_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.bpa.2010.10.005","volume":"24","author":"D Sargin","year":"2010","unstructured":"Sargin D, Friedrichs H, El-Kordi A, Ehrenreich H. (2010) Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research. Best. Pract. Res. Clin. Anaesthesiol. 24:573\u201394.","journal-title":"Best. Pract. Res. Clin. Anaesthesiol."},{"key":"1901223_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/1756285608098422","volume":"1","author":"C Bartels","year":"2008","unstructured":"Bartels C, Spate K, Krampe H, Ehrenreich H. (2008) Recombinant human erythropoietin: novel strategies for neuroprotective\/neuro-regenerative treatment of multiple sclerosis. Ther. Adv. Neurol. Disord. 1:193\u2013206.","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"Suppl 1","key":"1901223_CR3","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1038\/sj.cdd.4401450","volume":"11","author":"P Ghezzi","year":"2004","unstructured":"Ghezzi P, Brines M. (2004) Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ. 11 Suppl 1:S37\u201344.","journal-title":"Cell Death Differ."},{"key":"1901223_CR4","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1161\/01.STR.0000132196.49028.a4","volume":"35","author":"L Wang","year":"2004","unstructured":"Wang L, Zhang Z, Wang Y, Zhang R, Chopp M. (2004) Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke. 35:1732\u20137.","journal-title":"Stroke"},{"key":"1901223_CR5","doi-asserted-by":"publisher","first-page":"e11016","DOI":"10.1371\/journal.pone.0011016","volume":"5","author":"L Zhang","year":"2010","unstructured":"Zhang L, et al. (2010) Erythropoietin amplifies stroke-induced oligodendrogenesis in the rat. PLoS One 5:e11016.","journal-title":"PLoS One"},{"key":"1901223_CR6","doi-asserted-by":"publisher","first-page":"9617","DOI":"10.1073\/pnas.1200554109","volume":"109","author":"M Mengozzi","year":"2012","unstructured":"Mengozzi M, et al. (2012) Erythropoietin-induced changes in brain gene expression reveal induction of synaptic plasticity genes in experimental stroke. Proc. Natl. Acad. Sci. U. S. A. 109:9617\u201322.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1901223_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0006-8993(02)03239-0","volume":"952","author":"D Agnello","year":"2002","unstructured":"Agnello D, et al. (2002) Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res. 952:128\u201334.","journal-title":"Brain Res."},{"key":"1901223_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jneuroim.2005.10.016","volume":"172","author":"C Savino","year":"2006","unstructured":"Savino C, et al. (2006) Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis. J. Neuroimmunol. 172:27\u201337.","journal-title":"J. Neuroimmunol."},{"key":"1901223_CR9","doi-asserted-by":"publisher","first-page":"e1924","DOI":"10.1371\/journal.pone.0001924","volume":"3","author":"R Yuan","year":"2008","unstructured":"Yuan R, et al. (2008) Erythropoietin: a potent inducer of peripheral immuno\/inflammatory modulation in autoimmune EAE. PLoS ONE 3:e1924.","journal-title":"PLoS ONE"},{"key":"1901223_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2249.2010.04238.x","volume":"162","author":"SJ Chen","year":"2010","unstructured":"Chen SJ, et al. (2010) Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis. Clin Exp Immunol 162:210\u201323.","journal-title":"Clin Exp Immunol"},{"key":"1901223_CR11","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/ana.20274","volume":"56","author":"W Li","year":"2004","unstructured":"Li W, et al. (2004) Beneficial effect of erythropoietin on experimental allergic encephalomyelitis. Ann. Neurol. 56:767\u201377.","journal-title":"Ann. Neurol."},{"key":"1901223_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.brainres.2004.11.036","volume":"1034","author":"J Zhang","year":"2005","unstructured":"Zhang J, et al. (2005) Erythropoietin treatment improves neurological functional recovery in EAE mice. Brain Res. 1034:34\u20139.","journal-title":"Brain Res."},{"key":"1901223_CR13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.2119\/molmed.2011.00457","volume":"18","author":"N Hagemeyer","year":"2012","unstructured":"Hagemeyer N, et al. (2012) Erythropoietin attenuates neurological and histological consequences of toxic demyelination in mice. Mol. Med. 18:628\u201335.","journal-title":"Mol. Med."},{"key":"1901223_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.bbrc.2011.12.029","volume":"417","author":"YK Cho","year":"2012","unstructured":"Cho YK, et al. (2012) Erythropoietin promotes oligodendrogenesis and myelin repair following lysolecithin-induced injury in spinal cord slice culture. Biochem. Biophys. Res. Commun. 417:753\u20139.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1901223_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0168-0102(02)00161-X","volume":"44","author":"M Sugawa","year":"2002","unstructured":"Sugawa M, Sakurai Y, Ishikawa-Ieda Y, Suzuki H, Asou H. (2002) Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation. Neurosci. Res. 44:391\u2013403.","journal-title":"Neurosci. Res."},{"key":"1901223_CR16","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/S0140-6736(10)60992-0","volume":"375","author":"P Ghezzi","year":"2010","unstructured":"Ghezzi P, et al. (2010) Erythropoietin: not just about erythropoiesis. Lancet. 375:2142.","journal-title":"Lancet"},{"key":"1901223_CR17","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1073\/pnas.89.6.2140","volume":"89","author":"SS Watowich","year":"1992","unstructured":"Watowich SS, et al. (1992) Homodimerization and constitutive activation of the erythropoietin receptor. Proc. Natl. Acad. Sci. U. S. A. 89:2140\u20134.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1901223_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1126\/science.1098313","volume":"305","author":"M Leist","year":"2004","unstructured":"Leist M, et al. (2004) Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science. 305:239\u201342.","journal-title":"Science"},{"key":"1901223_CR19","doi-asserted-by":"publisher","first-page":"10925","DOI":"10.1073\/pnas.0805594105","volume":"105","author":"M Brines","year":"2008","unstructured":"Brines M, et al. (2008) Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc. Natl. Acad. Sci. U. S. A. 105:10925\u201330.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1901223_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1089\/neu.2009.1001","volume":"27","author":"Y Xiong","year":"2010","unstructured":"Xiong Y, et al. (2010) Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor. J. Neurotrauma. 27:205\u201315.","journal-title":"J. Neurotrauma."},{"key":"1901223_CR21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1242\/dev.129.2.505","volume":"129","author":"X Yu","year":"2002","unstructured":"Yu X, et al. (2002) Erythropoietin receptor signalling is required for normal brain development. Development. 129:505\u201316.","journal-title":"Development"},{"key":"1901223_CR22","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.cellsig.2006.08.014","volume":"19","author":"M Um","year":"2007","unstructured":"Um M, Gross AW, Lodish HF. (2007) A \u201cclassical\u201d homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells. Cell Signal. 19:634\u201345.","journal-title":"Cell Signal."},{"key":"1901223_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s004010000297","volume":"101","author":"AL Siren","year":"2001","unstructured":"Siren AL, et al. (2001) Erythropoietin and erythropoietin receptor in human ischemic\/hypoxic brain. Acta. Neuropathol. 101:271\u20136.","journal-title":"Acta. Neuropathol."},{"key":"1901223_CR24","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2119\/molmed.2011.00414","volume":"18","author":"M Brines","year":"2012","unstructured":"Brines M, Cerami A. (2012) The receptor that tames the innate immune response. Mol. Med. 18:486\u201396.","journal-title":"Mol. Med."},{"key":"1901223_CR25","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.bbamcr.2011.04.006","volume":"1813","author":"A Annenkov","year":"2011","unstructured":"Annenkov A, et al. (2011) A chimeric receptor of the insulin-like growth factor receptor type 1 (IGFR1) and a single chain antibody specific to myelin oligodendrocyte glycoprotein activates the IGF1R signalling cascade in CG4 oligoden-drocyte progenitors. Biochim. Biophys. Acta. 1813:1428\u201337.","journal-title":"Biochim. Biophys. Acta."},{"key":"1901223_CR26","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s10571-011-9685-2","volume":"31","author":"M Wang","year":"2011","unstructured":"Wang M, Doucette JR, Nazarali AJ. (2011) Conditional Tet-regulated over-expression of Hoxa2 in CG4 cells increases their proliferation and delays their differentiation into oligodendrocyte-like cells expressing myelin basic protein. Cell Mol. Neurobiol. 31:875\u201386.","journal-title":"Cell Mol. Neurobiol."},{"key":"1901223_CR27","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/371796a0","volume":"371","author":"P Topilko","year":"1994","unstructured":"Topilko P, et al. (1994) Krox-20 controls myelination in the peripheral nervous system. Nature. 371:796\u20139.","journal-title":"Nature"},{"key":"1901223_CR28","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1089\/10430340252898984","volume":"13","author":"C Demaison","year":"2002","unstructured":"Demaison C, et al. (2002) High-level transduction and gene expression in hematopoietic repopulating cells using a human imunodeficiency [immunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum. Gene Ther. 13:803\u201313.","journal-title":"Hum. Gene Ther."},{"key":"1901223_CR29","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1002\/jnr.22473","volume":"88","author":"ZY Chen","year":"2010","unstructured":"Chen ZY, Wang L, Asavaritkrai P, Noguchi CT. (2010) Up-regulation of erythropoietin receptor by nitric oxide mediates hypoxia preconditioning. J. Neurosci. Res 88:3180\u20138.","journal-title":"J. Neurosci. Res"},{"key":"1901223_CR30","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.mcn.2005.10.014","volume":"31","author":"PL Zhang","year":"2006","unstructured":"Zhang PL, et al. (2006) Increased myelinating capacity of embryonic stem cell derived oligodendrocyte precursors after treatment by interleukin-6\/ soluble interleukin-6 receptor fusion protein. Mol. Cell. Neurosci. 31:387\u201398.","journal-title":"Mol. Cell. Neurosci."},{"key":"1901223_CR31","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.expneurol.2007.08.022","volume":"208","author":"PL Zhang","year":"2007","unstructured":"Zhang PL, et al. (2007) Induction of neuronal and myelin-related gene expression by IL-6-receptor\/IL-6: a study on embryonic dorsal root ganglia cells and isolated Schwann cells. Exp. Neurol. 208:285\u201396.","journal-title":"Exp. Neurol."},{"key":"1901223_CR32","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1073\/pnas.051606598","volume":"98","author":"AL Siren","year":"2001","unstructured":"Siren AL, et al. (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. U. S. A. 98:4044\u20139.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1901223_CR33","doi-asserted-by":"publisher","first-page":"7174","DOI":"10.1523\/JNEUROSCI.0150-08.2008","volume":"28","author":"AI Flores","year":"2008","unstructured":"Flores AI, et al. (2008) Constitutively active Akt induces enhanced myelination in the CNS. J. Neurosci. 28:7174\u201383.","journal-title":"J. Neurosci."},{"key":"1901223_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.33549\/physiolres.930749","volume":"55","author":"K Genc","year":"2006","unstructured":"Genc K, Genc S, Baskin H, Semin I. (2006) Erythropoietin decreases cytotoxicity and nitric oxide formation induced by inflammatory stimuli in rat oligodendrocytes. Physiol. Res. 55:33\u20138.","journal-title":"Physiol. Res."},{"key":"1901223_CR35","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/jnr.22702","volume":"89","author":"S Kato","year":"2011","unstructured":"Kato S, et al. (2011) Endogenous erythropoietin from astrocyte protects the oligodendrocyte precursor cell against hypoxic and reoxygenation injury. J. Neurosci. Res 89:1566\u201374.","journal-title":"J. Neurosci. Res"},{"key":"1901223_CR36","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1093\/brain\/awm203","volume":"130","author":"H Ehrenreich","year":"2007","unstructured":"Ehrenreich H, et al. (2007) Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain. 130:2577\u201388.","journal-title":"Brain"},{"key":"1901223_CR37","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1161\/STROKEAHA.109.570325","volume":"41","author":"M Iwai","year":"2010","unstructured":"Iwai M, et al. (2010) Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic\/ischemic brain injury. Stroke. 41:1032\u20137.","journal-title":"Stroke"},{"key":"1901223_CR38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/path.2862","volume":"224","author":"M Yamada","year":"2011","unstructured":"Yamada M, Burke C, Colditz P, Johnson DW, Gobe GC. (2011) Erythropoietin protects against apoptosis and increases expression of nonneuronal cell markers in the hypoxia-injured developing brain. J. Pathol. 224:101\u20139.","journal-title":"J. Pathol."},{"key":"1901223_CR39","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.neuroscience.2010.04.070","volume":"169","author":"SR McIver","year":"2010","unstructured":"McIver SR, et al. (2010) Oligodendrocyte degeneration and recovery after focal cerebral ischemia. Neuroscience. 169:1364\u201375.","journal-title":"Neuroscience"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2013.00013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.2119\/molmed.2013.00013\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.crossref.org\/molmed.2013.00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2013.00013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T05:05:00Z","timestamp":1690866300000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2013.00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["1901223"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2013.00013","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"18 February 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}